1 Ocak 2020 Dergi makalesi Açık Erişim

Balcioglu, Bertan Koray; Oncu, Melis Denizci; Ozturk, Hasan Umit; Yucel, Fatima; Kaya, Filiz; Serhatli, Muge; Polat, Hivda Ulbegi; Tekin, Saban; Bahadir, Aylin Ozdemir

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
    <subfield code="a">Creative Commons Attribution</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:89241</subfield>
    <subfield code="p">user-tubitak-adresli-yayinlar</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">In December 2019 a novel coronavirus was detected in Wuhan City of Hubei Province-China. Owing to a high rate of transmission from human to human, the new virus called SARS-CoV-2 differed from others by its unexpectedly rapid spread. The World Health Organization (WHO) described the most recent coronavirus epidemic as a global pandemic in March 2020. The virus spread triggered a health crisis (the COVID-19 disease) within three months, with socioeconomic implications. No approved targeted-therapies are available for COVID-19, yet. However, it is foreseen that antibody-based treatments may provide an immediate cure for patients. Current neutralizing antibody development studies primarily target the S protein among the structural elements of SARS-CoV-2, which mediates the cell entry of the virus through the angiotensin converting enzyme 2 (ACE2) receptor of host cells. This review aims to provide some of the neutralizing antibody development strategies for SARS-CoV-2 and in vitro and in vivo neutralization assays.</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-adresli-yayinlar</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="n">3</subfield>
    <subfield code="v">44</subfield>
    <subfield code="c">203-214</subfield>
    <subfield code="p">TURKISH JOURNAL OF BIOLOGY</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2020-01-01</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.3906/biy-2005-91</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <controlfield tag="001">89241</controlfield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Balcioglu, Bertan Koray</subfield>
    <subfield code="u">TUBITAK, Genet Engn &amp; Biotechnol Inst, Marmara Res Ctr, Kocaeli, Turkey</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/89241/files/10-3906-biy-2005-91.pdf</subfield>
    <subfield code="s">2390419</subfield>
    <subfield code="z">md5:76ddac062799eaad29e2b237c392d85a</subfield>
  </datafield>
  <controlfield tag="005">20210316113528.0</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Oncu, Melis Denizci</subfield>
    <subfield code="u">TUBITAK, Genet Engn &amp; Biotechnol Inst, Marmara Res Ctr, Kocaeli, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ozturk, Hasan Umit</subfield>
    <subfield code="u">TUBITAK, Genet Engn &amp; Biotechnol Inst, Marmara Res Ctr, Kocaeli, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Yucel, Fatima</subfield>
    <subfield code="u">TUBITAK, Genet Engn &amp; Biotechnol Inst, Marmara Res Ctr, Kocaeli, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kaya, Filiz</subfield>
    <subfield code="u">TUBITAK, Genet Engn &amp; Biotechnol Inst, Marmara Res Ctr, Kocaeli, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Serhatli, Muge</subfield>
    <subfield code="u">TUBITAK, Genet Engn &amp; Biotechnol Inst, Marmara Res Ctr, Kocaeli, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Polat, Hivda Ulbegi</subfield>
    <subfield code="u">TUBITAK, Genet Engn &amp; Biotechnol Inst, Marmara Res Ctr, Kocaeli, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Tekin, Saban</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Bahadir, Aylin Ozdemir</subfield>
    <subfield code="u">TUBITAK, Genet Engn &amp; Biotechnol Inst, Marmara Res Ctr, Kocaeli, Turkey</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">SARS-CoV-2 neutralizing antibody development strategies</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
</record>